Sinocelltech Group Limited Class ASSE: 688520

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C

· Issued by Sinocelltech Group Limited Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Recombinant Shingles Vaccine SCTV04C

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis